| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.16 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |